Nucleai
AI-Driven Spatial Biomarkers
Tel Aviv, Israel · Founded 2017 · $47.0M raised
- Headquarters
- Tel Aviv
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- nucleai.ai
- Total Funding
- $47.0M
- Last Round
- $33.0M Series B
- Rounds
- 2
About
AI-powered spatial biology platform using computer vision to analyze tissue architecture and identify cancer biomarkers.
Summary
Nucleai is an Artificial Intelligence company based in Tel Aviv, Israel, founded in 2017. It has raised $47.0M in total across 2 rounds. Investors include Section 32, M Ventures and Sanofi Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company